Evans syndrome is a combination of IMHA (immune-mediated hemolytic anemia) and IMTP (immune-mediated thrombocytopenia). This means a pet’s body attacks the red blood cells and platelets at the same ...

By U.S. Food and Drug Administration May 1, 2023 May 1, 2023Updated May 1, 2023 ...

In a series of studies, Varenzin-CA1 was shown to have a reasonable expectation of efficacy in managing anemia in CKD cats. By day 28, 50% of cats given Varenzin-CA1 had increased their red blood ...

Varenzin-CA1 is indicated for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats. Varenzin-CA1 Important Safety Information For oral use in cats only.

(RTTNews) - The U.S. Food and Drug Administration conditionally approved Elanco US Inc.'s Varenzin-CA1 (molidustat oral suspension) for treating anemia in cats with chronic kidney disease or CKD.